Drug Trial Radar · NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Apr 28, 2025
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- SystImmune Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Conditions
- Small Cell Lung Cancer Metastatic or Locally Advanced
- Neuroendocrine Cancer
- Metastatic Neuroendocrine Prostate Cancer
- Metastatic Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
- Metastatic Advanced Merkel Cell Carcinoma
- Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung
- Locally Advanced Extrapulmonary Neuroendocrine Carcinoma
- Locally Advanced Neuroendocrine Prostate Cancer
- Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine
- Locally Advanced Merkel Cell Carcinoma
- Metastatic Large Cell Neuroendocrine Carcinoma of the Lung
Interventions
BL-M14D1Drug
BL-M14D1 will be administered on D1 every 3 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess safety and tolerability of BL-M14D1Time frame: 18 months
Locations
32 sites in 3 countries. Site status is shown where the registry gives one.
Clearview Cancer Institute
Huntsville, Alabama · Recruiting
OPN Healthcare
Glendale, California · Recruiting
MemorialCare Long Beach Medical Center
Long Beach, California · Recruiting
Valkyrie Clinical Trials
Los Angeles, California · Recruiting
UCLA
Los Angeles, California · Recruiting
UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center)
San Francisco, California · Recruiting
University of Colorado - Anschutz Cancer Pavilion
Aurora, Colorado · Recruiting
Valkyrie Denver
Lakewood, Colorado · Not yet recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
Emory Winship
Atlanta, Georgia · Recruiting
Tulane School of Medicine
New Orleans, Louisiana · Recruiting
START - New Jersey
East Brunswick, New Jersey · Recruiting
John Theurer Cancer Center-Hackensack
Hackensack, New Jersey · Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
Providence Cancer Institute
Portland, Oregon · Recruiting
Prisma Health Cancer Institute
Greenville, South Carolina · Recruiting
NEXT Dallas
Dallas, Texas · Recruiting
START Dallas- Fort Worth
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
NEXT Houston
Houston, Texas · Recruiting
START- San Antonio
San Antonio, Texas · Recruiting
NEXT Oncology Virginia
Fairfax, Virginia · Recruiting
University of Washington/Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
LTD "High Technology Hospital Medcenter"
Batumi, Georgia · Recruiting
JSC "Vian"
Kutaisi, Georgia · Recruiting
LTD "New Hospitals"
Tbilisi, Georgia · Recruiting
LTD "Pineo Medical Ecosystem"
Tbilisi, Georgia · Recruiting
LLC "Caucasus Medical Centre"
Tbilisi, Georgia · Recruiting
Regional Municipal Nonprofit Enterprise "Bukovinian clinical oncology center" of the Chernivtsi Regional Council
Chernivtsi, Ukraine · Not yet recruiting
"The Municipal Enterprise "Volyn Regional Clinical Hospital" of the Volyn Regional Council, Regional Medical Oncology Centre"
Lutsk, Ukraine · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.